Darolutamide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Darolutamide and local guidelines before prescribing.

Antiandrogen

Mechanism

Androgen receptor inhibitor.

Uses

Prostate cancer.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Fatigue, rash, raised liver enzymes.

Interactions

CYP3A4 and P-gp inducers.

Contraindications and cautions

Pregnancy

Monitoring

LFT

Pregnancy and breastfeeding

Not applicable

Renal and hepatic impairment

Reduce dose in severe renal impairment

Overdose and reversal

Supportive

Special advice

Continue GnRH therapy.

More from the textbook: uses, cautions and other points
Where it is discussed in the book